1 / 4

Parkinson’s Disease Drug market

The global Parkinsonu2019s disease drug market is anticipated to grow at a CAGR of over 6% during the forecast period.

kashif1
Download Presentation

Parkinson’s Disease Drug market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Parkinson’s Disease Drug Market Size, Growth Analysis Report, Forecast to 2027 Global Parkinson’s Disease Drug Market Size, Growth Analysis Report, Forecast to 2027 Global Parkinson’s Disease Drug Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 Global Parkinson’s Disease Drug Parkinson’s Disease Drug Market Trends | Segmentation, Outlook, Industry Report to 2021-2027 The global Parkinson’s disease drug market is anticipated to grow at a CAGR of over 6% during the forecast period. Parkinson’s disease is a progressive nervous system disorder. Parkinson’s disease affects the movement of the body and the symptoms start gradually. In some cases, symptoms start with a barely noticeable tremor in just one hand and go further to affect other parts. Along with tremors, Parkinson’s disease also commonly causes stiffness or slowing of movement in patients. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/parkinsons-disease-drug- market The global Parkinson’s disease drug market is segmented on the basis of the drug class into dopamine receptor agonists, MAO-inhibitors, carbidopa-levodopa, catechol O- methyltransferase (COMT) inhibitors, anticholinergics, and others. The other subsegment includes amantadine and selegiline. Secondary Sources Include:  Financial reports of companies involved in the market  Whitepapers research-papers, and news blogs  Company websites and their product catalogue The report is intended for a healthcare service provider, medical device companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions. A Full Report of Global Parkinson’s Disease Drug Marketis Available at: https://www.omrglobal.com/industry-reports/parkinsons-disease-drug-market Market Overview and Insights  Scope of the Report

  2. Analyst Insight & Current Market Trends  Key Findings  Recommendations  Conclusion  Rules & Regulations Market Segmentation  Global Parkinson’s Disease Drugs Market by Drug Class  Dopamine Receptor Agonists  MAO-Inhibitors  Carbidopa-Levodopa  Catechol O-methyltransferase (COMT) Inhibitors  Anticholinergics  Others(Amantadine, Selegiline) Company Profiles  AbbVie Inc.  ACADIA Pharmaceuticals Inc.  Apotex Inc.  Axovant Gene Therapies Ltd.  Boehringer Ingelheim GmbH  Bausch Health Companies Inc.  Boston Scientific Corp.  Cipla Inc.  Daiichi Sankyo Espha Co., Ltd.  Eli Lilly & Co.  Eisai Co., Ltd.  F. Hoffmann-La Roche AG  GlaxoSmithKline Plc

  3. Impax Laboratories, Inc.  Merck & Co. Inc.  Mylan NV  Novartis International AG  Orion Corp.  Pfizer Inc.  Sanofi SA  Teva Pharmaceutical Industries Ltd.  Vertical Pharmaceuticals, LLC  Wockhardt Ltd. Regional Analysis North America  United States  Canada Europe  UK  Germany  Italy  Spain  France  Rest of Europe Asia-Pacific  China  India  Japan  Rest of Asia-Pacific

  4. Rest of the World Global Parkinson’s Disease Drug Market– Segment by Region North America  United States  Canada Europe  Germany  United Kingdom  France  Spain  Italy  Rest of Europe Europe  North-American  Japan  India  Rest of North-American Rest of the World  Latin America  Middle East and Africa For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/parkinsons-disease-drug-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related